ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Dicyclohexylcarbodiimide → (4R,6R)-6-{2-[(1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-6-t-butyldimethylsilyloxy-8-(3,3-dimethylbutyryloxy)-2-methyl-1-naphthyl]ethyl}tetrahydro-4-t-butyldimethylsilyloxy-2H-pyran-2-one

HRID 400135
ノート
印刷プレビュー

反応式

HRID 400135 の反応式
[CH3:1][C:2]([CH3:8])([CH3:7])[CH2:3][C:4]([OH:6])=[O:5].C1(N=C=NC2CCCCC2)CCCCC1.N1(C2C=CN=CC=2)CCCC1.[Si:35]([O:42][C@H:43]1[CH2:52][C@H:51](O)[C@H:50]2[C:45]([CH:46]=[CH:47][C@H:48]([CH3:71])[C@@H:49]2[CH2:54][CH2:55][C@H:56]2[O:61][C:60](=[O:62])[CH2:59][C@H:58]([O:63][Si:64]([C:67]([CH3:70])([CH3:69])[CH3:68])([CH3:66])[CH3:65])[CH2:57]2)=[CH:44]1)([C:38]([CH3:41])([CH3:40])[CH3:39])([CH3:37])[CH3:36]>C(Cl)Cl>[Si:35]([O:42][C@H:43]1[CH2:52][C@H:51]([O:5][C:4](=[O:6])[CH2:3][C:2]([CH3:8])([CH3:7])[CH3:1])[C@H:50]2[C:45]([CH:46]=[CH:47][C@H:48]([CH3:71])[C@@H:49]2[CH2:54][CH2:55][C@H:56]2[O:61][C:60](=[O:62])[CH2:59][C@H:58]([O:63][Si:64]([C:67]([CH3:70])([CH3:69])[CH3:68])([CH3:65])[CH3:66])[CH2:57]2)=[CH:44]1)([C:38]([CH3:39])([CH3:40])[CH3:41])([CH3:37])[CH3:36]
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 10868DicyclohexylcarbodiimideHCID 14057tert-Butylacetic acidHCID 755674-PyrrolidinopyridineHCID 14600906Pravastatin Diol Lactone Di-(tert-butyldimethylsilyl) Ether

生成物 1

HCID 53987405(4R,6R)-6-{2-[(1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-6-t-butyldimethylsilyloxy-8-(3,3-dimethylbutyryloxy)-2-methyl-1-naphthyl]ethyl}tetrahydro-4-t-butyldimethylsilyloxy-2H-pyran-2-one
収率 47.5%

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒

実験手順

0.46 ml (3.6 mmol) of 3,3-dimethylbutyric acid, 741 mg (3.6 mmol) of dicyclohexyl carbodiimide and 13 mg (0.09 mmol) of 4-(1-pyrrolidinyl)pyridine were added to a solution of 1.00 g (1.8 mmol) of (4R,6R)-6-{2-[(1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-hexahydro-6-t-butyldimethylsilyloxy-8-hydroxy-2-methyl-1-naphthyl]ethyl}tetrahydro-4-t-butyldimethylsilyloxy-2H-pyran-2-one [prepared as described in Example B, above] in 15 ml of methylene chloride, whilst ice-cooling. The resulting mixture was stirred at the same temperature for 30 minutes and then stirred at room temperature for a further 19 hours. At the end of this time, the solvent was removed by distillation under reduced pressure and the resulting residue was mixed with 20 ml of diethyl ether. Any insoluble material was removed by filtration and then washed twice with diethyl ether, using 5 ml for each washing. The filtrate and the washings were then combined and the solvent was removed by distillation under reduced pressure. The resulting residue was purified by flash column chromatography through silica gel, using a 4:1 by volume mixture of hexane and ethyl acetate as the eluent, to give 555 mg (47% yield) of the title compound.

後処理

  1. customprepared
  2. stirringstirred at room temperature for a further 19 hours
  3. customAt the end of this time, the solvent was removed by distillation under reduced pressure
  4. additionthe resulting residue was mixed with 20 ml of diethyl ether
  5. customAny insoluble material was removed by filtration
  6. washwashed twice with diethyl ether
  7. customthe solvent was removed by distillation under reduced pressure
  8. customThe resulting residue was purified by flash column chromatography through silica gel
  9. additionby volume mixture of hexane and ethyl acetate as the eluent

出典と根拠

ORDレコード
ord-898fbef8cfc7426686b02ad7530fd3a1
出典データセット
uspto-grants-1998_10
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US05827855

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート